ICICI Lombard and Arya.ai Set a New Standard in Insurance Automation
MUMBAI, India, Nov. 29, 2024 /PRNewswire/ -- ICICI Lombard, one of India's…
Global initiative launched to train scientists to safely test cosmetics, chemicals without painful and archaic animal experiments
BRUSSELS, Nov. 27, 2024 /PRNewswire/ -- A new online Master Class course…
Olympism365: Nine enterprises to receive grants for sport development projects
26 November 2024 - Nine social enterprises will benefit from grants totalling USD…
Olympism365: Funding local innovators for social development through sport
25 November 2024 - The International Olympic Committee (IOC) will provide USD…
Lingokids Demonstrates Effective Child Learning in Just 8 Weeks: Results from an Efficacy Study
Improvements of 6% in literacy, 7% in math, and 10% in socio-emotional…
IBM Champions Generative AI and Automation to Safeguard Security Across AWS Environments
IBM's Autonomous Security for Cloud solution to help organizations transition to cloud-based…
AlveoGene Receives Rare Pediatric Disease Designation (RPDD)from FDA for AVG-002, its Novel, Inhaled Gene Therapy forLethal Neonatal Surfactant Protein B (SP-B) Deficiency
Inherited SP-B deficiency is an ultra-rare monogenic cause of fatal respiratory distress…
New Economist Impact Study Finds Only 22% of Enterprises Believe Their IT Infrastructure is Ready for AI
85% of global enterprises are actively using or testing generative AI in…
INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer’s Disease
Boca Raton, Florida, Nov. 13, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:…
Binance Labs Invests in BIO Protocol to Accelerate Decentralized Science (DeSci) Funding
Main Takeaways: Binance Labs has invested in BIO Protocol, a pioneering protocol transforming…